Evidence map›Paper›PMID 25895972›Full record

ArticleInfection and immunity2015

AP-1 Transcription Factor Serves as a Molecular Switch between Chlamydia pneumoniae Replication and Persistence.

S Krämer, P Crauwels, R Bohn, C Radzimski, M Szaszák, M Klinger, J Rupp, G van Zandbergen

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Assessing the validity of leucine zipper constructs predicted by AlphaFold.Protein science : a publication of the Protein Society · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Frontiers in cellular and infection microbiology · 2023
    Article
  6. AssayingMolecules (Basel, Switzerland) · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

S KrämerDivision of Immunology, Paul Ehrlich Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
P CrauwelsDivision of Immunology, Paul Ehrlich Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
R BohnDivision of Immunology, Paul Ehrlich Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
C RadzimskiInstitute of Medical Microbiology and Hygiene, University of Luebeck, Luebeck, Germany.
M SzaszákInstitute of Medical Microbiology and Hygiene, University of Luebeck, Luebeck, Germany.
M KlingerInstitute of Anatomy, Center for Structural and Cell Biology in Medicine, University of Luebeck, Luebeck, Germany.
J RuppInstitute of Medical Microbiology and Hygiene, University of Luebeck, Luebeck, Germany Department of Molecular und Clinical Infectious Diseases, University of Luebeck, Luebeck, Germany.
G van ZandbergenDivision of Immunology, Paul Ehrlich Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany Institute of Immunology, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany Ger.Zandbergen@pei.de.
Paul Ehrlich Institut · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlamydia pneumoniae is a Gram-negative bacterium that causes acute or chronic respiratory infections. As obligate intracellular pathogens, chlamydiae efficiently manipulate host cell processes to ensure their intracellular development. Here we focused on the interaction of chlamydiae with the host cell transcription factor activator protein 1 (AP-1) and its consequence on chlamydial development. During Chlamydia pneumoniae infection, the expression and activity of AP-1 family proteins c-Jun, c-Fos, and ATF-2 were regulated in a time- and dose-dependent manner. We observed that the c-Jun protein and its phosphorylation level significantly increased during C. pneumoniae development. Small interfering RNA knockdown of the c-Jun protein in HEp-2 cells reduced the chlamydial load, resulting in smaller inclusions and significantly lower chlamydial recovery. Furthermore, inhibition of the c-Jun-containing AP-1 complexes using tanshinone IIA changed the replicative infection phenotype into a persistent one. Tanshinone IIA-dependent persistence was characterized by smaller, aberrant inclusions, a strong decrease in the chlamydial load, and significantly reduced chlamydial recovery, as well as by the reversibility of the reduced recovery after the removal of tanshinone IIA. Interestingly, not only was tanshinone IIA treatment accompanied by a significant decrease of ATP levels, but fluorescence live cell imaging analysis by two-photon microscopy revealed that tanshinone IIA treatment also resulted in a decreased fluorescence lifetime of protein-bound NAD(P)H inside the chlamydial inclusion, indicating that chlamydial reticulate bodies have decreased metabolic activity. In all, these data demonstrate that the AP-1 transcription factor is involved in C. pneumoniae development, with tanshinone IIA treatment resulting in persistence.

Indexed as

Gene Expression Regulation, BacterialHost-Pathogen InteractionsTranscription, GeneticBacterial LoadChlamydophila pneumoniaeHepatocytesHep G2 CellsHumansTranscription Factor AP-1Transcription Factor AP-1

Identifiers

PMID25895972
PMCPMC4468534
OpenAlexW2091139725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.